MMSL 2014, 83(1):34-39 | DOI: 10.31482/mmsl.2014.006

RAPID INFORMATIVE SCREENING OF NANO-ALAPTIDE AS POTENTIAL TRANSDERMAL PERMEATION ENHANCER OF ACETYLSALICYLIC ACID AND PARACETAMOLOriginal article

Aneta Černíková, Radka Opatřilová, Josef Jampílek*
Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1/3, 61242 Brno, Czech Republic

This investigation deals with the affection of permeation of acetylsalicylic acid and paracetamol applied in the system propylene glycol-water 1:1 through full-thickness pig ear skin by alaptide that was applied in nanonized form as a potential chemical penetration enhancer. Alaptide, (S)-8-methyl-6,9-diazaspiro[4.5]decan-7,10-dione, is the original Czech compound. The application of nanonized alaptide significantly enhanced the permeation of both drugs through the skin. Enhancement ratios in the studied time interval 0.5-2.0 h varied from 1.11 to 17.70 for acetylsalicylic acid and from 6.83 to 19.83 for paracetamol.

Keywords: alaptide; nanoparticles; chemical penetration enhancer; acetylsalicylic acid; paracetamol

Received: January 6, 2014; Revised: March 17, 2014; Published: April 7, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Černíková, A., Opatřilová, R., & Jampílek, J. (2014). RAPID INFORMATIVE SCREENING OF NANO-ALAPTIDE AS POTENTIAL TRANSDERMAL PERMEATION ENHANCER OF ACETYLSALICYLIC ACID AND PARACETAMOL. MMSL83(1), 34-39. doi: 10.31482/mmsl.2014.006
Download citation

References

  1. Benson, H.A.E. Transdermal drug delivery: Penetration enhancement techniques. Curr. Drug Deliv. 2005, 2, 23-33. Go to original source... Go to PubMed...
  2. Jampilek, J.; Brychtova, K. Azone analogues: Classification, design, and transdermal penetration principles. Med. Res. Rev. 2012, 32, 907-947. Go to original source... Go to PubMed...
  3. Jampilek, J. Transdermal application of drugs and techniques affecting skin barrier. J. Bioequiv. Availab. 2013, 5, 233-235. Go to original source...
  4. Vasilev, A.E.; Krasnyuk, I.I.; Ravikumar, S.; Tokhmakhchi, V.N. Transdermal therapeutic systems for controlled drug release. Pharm. Chem. J. 2001, 35, 613-626. Go to original source...
  5. Barry, B.W. Mode of action of penetration enhancers in human skin. J. Control Release 1987, 6, 85-97. Go to original source...
  6. Williams, A.C.; Barry, B.W. Penetration enhancers. Adv. Drug Deliv. Rev. 2004, 56, 603-618. Go to original source... Go to PubMed...
  7. Trommer, H.; Neubert, R.H.H. Overcoming the stratum corneum: The modulation of skin penetration. Skin Pharmacol. Physiol. 2006, 19, 106-121. Go to original source... Go to PubMed...
  8. Radl, S.; Kasafirek, E.; Krejci, I. Alaptide. Drugs Fut. 1990, 15, 445-447. Go to original source...
  9. Jampilek, J.; Opatrilova, R.; Rezacova, A.; Oktabec, Z.; Dohnal, J. Alaptide: Methods of effecting its solubility, membrane permeation and pharmaceutical compositions for human and veterinary applications. WO/2014/019556 A1, Feb 6, 2014.
  10. Jampilek, J.; Opatrilova, R.; Coufalova, L.; Cernikova, A.; Dohnal, J. Utilization of alaptide as transdermal penetration modifier in pharmaceutical compositions for human and veterinary applications containing anti-inflammatory drugs and/or antimicrobial chemotherapeutics WO/2013/020527 A1, Feb 14, 2013. Go to original source... Go to PubMed...
  11. Opatrilova, R.; Cernikova, A.; Coufalova, L.; Dohnal, J.; Jampilek, J. In vitro permeation of micronized and nanonized alaptide from semi-solid formulations, Sci. World J. 2013, 2013, Article ID 787283, 8 pages. Go to original source... Go to PubMed...
  12. Roth, H.J.; Fenner, H. Arzneistoffe, 3rd ed., Deutscher Apotheker Verlag, Stuttgart 2000.
  13. Liou, Y.B.; Ho, H.O.; Yang, C.J.; Lin, Y.K.; Sheu, M.T. Construction of a quantitative structure-permeability relationship (QSPR) for the transdermal delivery of NSAIDs. J. Control Release 2009, 138, 260-267. Go to original source... Go to PubMed...
  14. Sintov, A.; Gorodischer, R. Transdermal drug delivery system. WO/2002/009763 A2, Feb 7, 2002.
  15. Finnin, B.C.; Morgan, T.M. Transdermal penetration enhancers: Applications, limitations, and potential. J. Pharm. Sci. 1999, 88, 955-958. Go to original source... Go to PubMed...
  16. Kasafirek, E.; Rybak, M.; Krejci, I.; Sturs, A.; Krepela, E.; Sedo, A. Two-step generation of spirocyclic dipeptides from linear peptide ethyl ester precursors. Life Sci. 1992, 50, 187-193. Go to original source... Go to PubMed...
  17. Franz, T.J. Percutaneous absorption on the relevance of in vitro data. J. Invest. Dermatol. 1975, 64, 190-195. Go to original source... Go to PubMed...
  18. Jacobi, U.; Kaiser, M.; Toll, R.; Mangelsdorf, S.; Audring, H.; Otberg, N.; Sterry, W.; Lademann, J. Porcine ear skin: An in vitro model for human skin. Skin Res. Technol. 2007, 13, 19-24. Go to original source... Go to PubMed...
  19. Herkenne, C.; Naik, A.; Kalia, Y.N.; Hadgraft, J.; Guy, R.H. Pig ear skin ex vivo as a model for in vivo dermatopharmacokinetic studies in man. Pharm. Res. 2006, 23, 1850-1856. Go to original source... Go to PubMed...
  20. Meyer, W.; Schwarz, K.; Neurand, K.T. The skin of domestic mammals as a model for the human skin, with special reference to the domestic pig. Curr. Probl. Dermatol. 1978, 7, 39-52. Go to original source... Go to PubMed...
  21. Evrard, D.; Touitou, E.; Kolusheva, S.; Fishov, Y.; Jelinek, R. A new colorimetric assay for studying and rapid screening of membrane penetration enhancers. Pharm. Res. 2001, 18, 943-949. Go to original source... Go to PubMed...
  22. Williams, A.C.; Barry, B.W. Urea analogues in propylene glycol as penetration enhancers in human skin. Int. J. Pharm. 1989, 56, 43-50. Go to original source...
  23. Yamane, M.A.; Williams, A.C.; Barry B.W. Terpene penetration enhancers in propylene glycol-water co-solvent systems: Effectiveness and mechanism of action. J. Pharm. Pharmacol. 1995, 47, 978-989. Go to original source... Go to PubMed...
  24. Levang, A.K.; Zhao, K.; Singh, J. Effect of ethanol propylene glycol on the in vitro percutaneous absorption of aspirin, biophysical changes and macroscopic barrier properties of the skin. Int. J. Pharm. 1999, 181, 255-263. Go to original source... Go to PubMed...
  25. Gerber, M.; Breytenbach, J.C.; Hadgraft, J.; du Plessis, J. Synthesis and transdermal properties of acetylsalicylic acid and selected esters. Int. J. Pharm. 2006, 310, 31-36. Go to original source... Go to PubMed...
  26. Ammar, H.O.; Ghorab, M.; El-Nahhas, S.A.; Kamel, R. Design of a transdermal delivery system for aspirin as an antithrombotic drug. Int. J. Pharm. 2006, 327, 81-88. Go to original source... Go to PubMed...
  27. Polukhina, O.S.; Basok, I.B.; Salomatina, L.A.; Sevastianov, V.I. Experimental study of the pharmacokinetics of acetylsalicylic acid upon transdermal administration. Eksp. Klin. Farmakol. 2009, 72, 29-32.
  28. Sintov, A.C.; Krymberk, I.; Gavrilov, V.; Gorodischer, R. Transdermal delivery of paracetamol for paediatric use: Effects of vehicle formulations on the percutaneous penetration. J. Pharm. Pharmacol. 2003, 55, 911-919. Go to original source... Go to PubMed...
  29. Bhatt, P.P.; Rytting, J.H.; Topp, E.M. Influence of Azone® and lauryl alcohol on the transport of acetaminophen and ibuprofen through shed snake skin. Int. J. Pharm. 1991, 72, 219-226. Go to original source...